Distinct cadherin—catenin complexes in Ca2+ dependent cell—cell adhesion  by Butz, Stefan & Kemler, Rolf
FEBS Letters 355 (1994) 195-200 
FEBS 14818 
Distinct cadherin-catenin complexes in Ca2÷-dependent cell-cell adhesion 
Stefan Butz, Rolf Kemler* 
Max-Planck-Institut fiir Immunbiologie, D-79108 Freiburg, Germany 
Received 22 September 1994 
Abstract Catenins are peripheral cytoplasmic proteins originally identified in association with the mouse epithelial cell adhesion molecule 
E-cadherin. Molecular cloning and primary structure analysis demonstrated that a-catenin ishomologous tovinculin and that fl-catenin is homol- 
ogous to human plakoglobin and the Drosophila gene product armadillo. With the use of peptide-specific anti plakoglobin antibodies we confirm 
here that plakoglobin isa component of the cadherin-catenin complex and that it is most likely identical to 7-catenin. We show that plakoglobin 
binds directly to E-cadherin. We consolidate he biochemical evidence for the existence oftwo distinct and separable E-cadherin-catenin complexes 
in the same cell. One complex is composed of E-cadherin, ~- and fl-catenin, the other of E-cadherin, ~t-catenin a d plakoglobin. A similar distinct 
association with catenins i also found for other cadherins. Comparison of different cell ines revealed that he relative amounts of the two complexes 
vary depending on cell types. 
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1. Introduction 
Classical cadherins associate via their cytoplasmic domains 
with peripheral cytoplasmic proteins termed ~-, fl-, and 7-cat- 
enin, respectively 102, 88 and 80 kDa in size [1,2]. Several 
independent lines of evidence clearly point to the importance 
of catenins for cadherin-mediated c lladhesion (for review, see 
[3,4]). Molecular cloning and primary structure analysis of cat- 
enins revealed homologies to other peripheral cytoplasmic pro- 
teins. ~-Catenin s homologous tovinculin [5,6], a protein local- 
ized in adherens junctions and in focal contacts. Biochemical 
analysis indicated that ~t-catenin does not bind directly to the 
cytoplasmic domain of cadherins [7,8], rather mediating the 
connection of the cadherin-catenin complex with actin fila- 
ments [9]. The importance of ~-catenin for cadherin function 
has been demonstrated by transfection of the cDNA in 
~t-catenin deficient cells, which restored the cadherin-mediated 
cell adhesion [10]. fl-Catenin exhibits homology to human 
plakoglobin, a component of desmosomal p aques and adher- 
ens junctions [11,12], and to the product of the Drosophila 
segment polarity gene, armadillo [13,14]. Pulse-chase xperi- 
ments and the analysis of different non-ionic detergent cell 
lysates indicated that fl-catenin binds directly to E-cadherin [7]. 
The molecular identity of ~,-catenin has remained less well un- 
derstood. Recently it became evident hat plakoglobin is a 
component ofthe cadherin-catenin complex and that ~'-catenin 
is most likely identical to plakoglobin [15]. 
We have recently cloned the cDNAs encoding mouse 
fl-catenin and plakoglobin and produced specific anti-peptide 
antibodies for each protein [16]. With the use of these antibod- 
ies we confirm that plakoglobin is a component of the cad- 
herin-catenin complex and that it is most likely identical to 
7-catenin. Plakoglobin, like fl-catenin, binds directly to E-cad- 
herin. Our results how that two separable E-cadherin-catenin 
complexes exist in the same cell, one composed of E-cadherin, 
~- and fl-catenin, and the other of E-cadherin, ~-catenin and 
plakoglobin. These results agree with recent data from another 
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group [17,18] and provide further evidence for the existence of 
two distinct E-cadherin-catenin complexes in the same cell. We 
have also extended these studies to show variations in different 
cell types and implicate other cadherins. 
2. Materials and methods 
2.1. Cell culture 
The following cell lines were used: A431, human epidermoid carci- 
noma cells (ATCC CRL 1555); Int407, human embryonic ntestine cells 
(ATCC CCL 6); MDBK, bovine kidney cells (ATCC CCL 22); LLC- 
PK1, porcine kidney cells (ATCC CL 101); CMT, murine rectal carci- 
noma cells (ATCC CCL 223); CSG, salivary epithelial cells [19]; eEnd2, 
embryonic endothelioma cells [20] and PCC4azal, embryonal carci- 
noma cells [21]. LI-1 cells are derived from Ltk- cells transfected with 
E-cadherin cDNA [1]. All cell lines were cultured in Dulbecc, o's modi- 
fied Eagle's medium (DMEM) containing 15% FCS at 370C in a 10% 
CO2 atmosphere. For metabolic labelling experiments 2 x 107 cells were 
grown in methionine-free DMEM, supplemented with 10% dialysed 
FCS, for 2 h prior to the addition of 50 gCi/ml [35S]methionine (Amer- 
sham) for overnight incubation. 
2.2. Antibodies 
Affinity-purified rabbit antibodies raised against he extracellular 
part of E-cadherin have been described [1]. Rabbit antisera gainst 
a-catenin, p-catenin and plakoglobin were produced against synthetic 
peptides. The peptides, the coupling by glutaraldehyde to keyhole lim- 
pet hemocyanin (Sigma) and the immunization procedure have been 
described for a-catenin [5] and fl-catenin [16]. Anti-peptide antibodies 
recognizing the cognate sequence inplakoglobin were generated using 
resin-immobilized lysine-branched synthetic peptides. The peptide se- 
quence DGLRPPYPTADHMLA (in plakoglobin this sequence is lo- 
cated at the carboxy-terminus) was synthesized on a polystyrene--pol- 
yoxyethylene graft co-polymer carrying abranched heptalysine [22]. All 
anti-peptide antibodies were affinity purified using the corresponding 
peptide-resin conjugates. Mouse monoclonal ntibody 3.10 directed 
against desmoglein I was a kind gift of Dr. W.W. Franke (DKFZ, 
Heidelberg, Germany). 
2.3. Preparation of lysates 
Cells were washed three times with PBS at room temperature; all
following steps were performed at 4°C. Cell extracts were obtained by 
applying cold lysis buffer (800 gl per 2 x 10 7 cells) for 10 min; lysis 
buffer: 20 mM imidazole, pH 6.8; 100 mM KC1; 2 mM MgC12; 10 mM 
EGTA; 300 mM sucrose; 1mM Na-vanadate; 1 mM Na-molybdate; 
1 mM Na-fluoride; 0.2% Triton X-100 and 1 mM PMSF. Lysates were 
centrifuged twice at 16,000 x g for 5 min and then subjected to im- 
munoprecipitation. I  some experiments 0.2% Triton X-100 was 
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replaced by either 0.5% saponin, 0.5% digitonin, 0.02% lauryl dimethyl- 
amine oxide (LDAO), or 0.2% C8E4; or else 1% Triton X-100, 1 mM 
CaCI2, 1 mM PMSF in PBS, pH 7.4, was used. In some experiments, 
~-catenin was removed from the cadherin-catenin complex by treating 
the lysate or the immunoprecipitate with 40 mM octylglucoside (OG) 
as described before [7]. To analyze detergent-insoluble material, pellets 
obtained from the first centrifugation were washed two times with lysis 
buffer, mixed with lysis buffer containing 10% betaine, and subse- 
quently sonicated twice for 5 s each, at the highest level, with a probe 
sonicator (sonopuls, Bandelin, Berlin, Germany) with a probe of diam- 
eter 4 mm. After 20 min on ice, lysates were centrifuged at 16,000 xg 
for 5 min and supernatants were subjected to immunoprecipitations. 
2.4. Immunoprecipitation andimmunoblotting 
Immunoprecipitations were carried out at 4°C. Cell lysates were 
precleared by incubation for 1 h with 200 pl/ml lysate of 10% (w/v) 
protein A-Sepharose beads (Pharmacia, Freiburg, Germany) preab- 
sorbed with lysis buffer containing ovalbumin (1 mg/ml), then centri- 
fuged at 1,000 x g for 5 min, followed by centrifugation f the superna- 
tant at 16,000 xg for 5 min. Cell lysates equivalent to4 x 10 6 cells were 
incubated with the appropriate antibody (5 pg anti-E-cadherin, 10pg 
anti-ct-catenin, 30pg anti-fl-catenin a d 20/ag anti-plakoglobin) and 50 
pl protein A-Sepharose for 1 h. Beads were washed 5 times with lysis 
buffer supplemented with ovalbumin. In sequential immunoprecipita- 
tions a further incubation with protein A-Sepharose was intercalated 
to remove traces of unbound antibodies before the next immunoprecip- 
itation step was started. SDS-PAGE of the immunoprecipitates wa
performed under educing conditions [23] and gels were fluorographed 
or immunoblotted. For fluorography, gels were fixed in 10% acetic acid, 
incubated with 1 M Na-salicylate and subsequently dried. 
For immunodetection the proteins eparated by SDS-PAGE were 
transferred electrophoretically to nitrocellulose. Filters were blocked 
with 5% powdered milk disolved in 10 mM Tris-HC1, pH 7.4, 150 mM 
NaC1, 0.1% Tween 20, at 37°C for 1 h, and incubated with 2-5 pg/ml 
primary antibody and then with alkaline phosphatase-conjugated sec- 
ondary antibody (Dianova, Hamburg, Germany). Bound antibodies 
were detected using Nitro blue tetrazolium and 5-bromo-4-chloro-3- 
indolyl phosphate as substrates (NBT/BCIP) (Promega, Madison, 
USA). 
3. Results 
3.1. Two E-cadherin-catenin complexes 
Affinity-purified anti-peptide antibodies against mouse 
plakoglobin and fl-catenin were tested in immunoblots against 
lysates of various cell lines from mouse, human and several 
other mammalian species. The antibodies reacted each with a 
single protein, one of 88 kDa for fl-catenin and one of 80 kDa 
for plakoglobin (not shown). When E-cadherin-catenin com- 
plexes immunoprecipitated with anti-~-catenin a tibodies from 
metabolically abeled cell lysates of human epithelial A431 cells 
(Fig. l, lane 2) were probed with anti-plakoglobin antibodies, 
a protein of 80 kDa was detected, with an electrophoretic mo- 
bility identical to 7-catenin (Fig. l, lane 3). Immunoprecipitates 
collected with anti-E-cadherin antibodies gave identical results 
when subsequently stained with anti-plakoglobin on im- 
munoblots (not shown). These results confirm that plakoglobin 
is a component of the cadherin-catenin complex and that 
plakoglobin is most likely identical to y-catenin. Attempts to 
distinguish between 7-catenin and plakoglobin led only to de- 
tection of the 84 kDa proteolytic fragment of E-cadherin, which 
frequently arises in preparative analysis (H. Hoschiitzky and A. 
Scherer, unpublished results). To further elucidate the relation- 
ship between plakoglobin and the cadherin-catenin complex, 
immunoprecipitation experiments on cell lysates of metaboli- 
cally labeled cells were performed with either anti-fl-catenin or
anti-plakoglobin a tibodies. The relative amounts offl-catenin 
and plakoglobin in the immunoprecipitated complexes varied 
depending on whether anti-fl-catenin or anti-plakoglobin a ti- 
bodies were used for immunoprecipitations (Fig. 1, compare 
lanes 4 and 5). These results were an indication for two different 
E-cadherin-catenin complexes in a given cell, one composed of 
E-cadherin, ~- and fl-catenin, the other of E-cadherin, s-cat- 
enin and plakoglobin. Treatment of cell lysates or purified 
cadherin-catenin complexes with octylglucoside (40 mM) spe- 
cifically removes ct-catenin from the complex [7]. Such experi- 
ments were carried out to investigate the possible interaction 
of plakoglobin with the other components of the complex. As 
expected, the amount of ~-catenin was greatly reduced in the 
complex when cell lysates treated with octylglucoside were im- 
munoprecipitated with anti-fl-catenin antibodies (Fig. 1, lane 
6). Most remarkably, in analogous experiments performed with 
anti-plakoglobin antibodies, the complex immunoprecipitated 
was largely composed of E-cadherin and plakoglobin (Fig. 1, 
lane 7). These results indicate that plakoglobin, like fl-catenin, 
binds directly to the cytoplasmic domain of E-cadherin. 
Additional evidence for two E-cadherin-catenin complexes 
in the same cell was obtained by sequential immunoprecipita- 
tions: cell lysates were first depleted of one of the two 
complexes with either anti-fl-catenin or anti-plakoglobin 
antibodies, and the second complex was subsequently im- 
munoprecipitated with the other antibody. In either order, the 
second complex was clearly detectable in supernatants after 
depletion of the first (Fig. 2A,B). These results show that nei- 
ther fl-catenin or plakoglobin was reduced in the complex due 
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Fig. 1. Plakoglobin is a component of one of two distinct cadherin- 
catenin complexes and binds directly to E-cadherin. Cell lysates from 
metabolically abeled A431 cells solubilized in lysis buffer, 0.2% Triton 
X-100, were subjected to immunoprecipitation using affinity-purified 
antibodies specific for ct- or fl-catenin or plakoglobin. (Lane 1) Co, 
controls with no antibody. (Lane 2) Anti-ct-catenin precipitates (like 
anti-E-cadherin, not shown) the previously known complex composed 
of E-cadherin and catenins. Blotting of anti-~-catenin immunoprecipi- 
tates and subsequent s aining with anti-plakogiobin revealed that 
plakoglobin isa component ofthis complex (lane 3; IB pl, immunoblot 
with anti-plakoglobin a tibodies). Immunoprecipitates collected with 
anti-fl-catenin (lane 4) or anti-plakoglobin (lane 5) differed in the molec- 
ular composition of the cadherin-catenin complex in that either 
fl-catenin or plakoglobin was greatly reduced or absent in the two 
alternative immunoprecipitates. Cell lysates treated with 40 mM 
octylglucoside (OG) and immunoprecipitated with anti-fl-catenin (lane 
6) and anti-plakoglobin (lane 7) had ct-catenin specifically removed 
from the complex, thus demonstrating that plakoglobin binds directly 
to E-cadherin (lane 7). The positions of E-cadherin (E), ct-catenin (~), 
fl-catenin (fl) and plakoglobin (pl) are indicated on the left. 
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Fig. 2. Two distinct E-cadherin-catenin complexes inthe same cell are 
separable by sequential immunoprecipitations. These were performed 
with anti-fl-catenin and anti-plakoglobin a tibodies on cell lysates of 
metabolically abeled A431 cells. In panel A, cell lysates were first 
depleted with anti-fl-catenin (fl) and unbound material was subse- 
quently immunoprecipitated with anti-plakoglobin (pl); in panel B the 
order was reversed: first depletion with anti-plakoglobin (pl) followed 
by anti-fl-catenin (fl). An intermediate step with protein A-Sepharose 
(PA) was intercalated toremove residual antibodies. After depletion of 
cell lysates with both anti-fl-catenin and anti-plakoglobin, o E-cad- 
herin (E) was detected inthe remaining supernatant by immunoprecip- 
itation, but free ~-catenin (ct) was present. 
to interference by the bound anti-plakoglobin oranti-fl-catenin 
antibodies. Additional immunoprecipitations with anti-E-cad- 
herin antibodies revealed no free E-cadherin, but from the 
depleted supernatants free ~t-catenin was detectable with anti- 
0~-catenin antibodies (Fig. 2A,B). This finding verifies earlier 
observations pointing to a pool of free ct-catenin in a cell. 
The two distinct cadherin-catenin complexes were found re- 
producibly, independent of cell culture or cell lysis conditions, 
including the following experimental parameters: (i) growth 
support (polystyrene c ll culture dishes or porous polycarbon- 
ate membrane inserts); (ii) confluency of cell cultures (semlcon- 
fluent, 2 days confluent, or 5 days confluent); (iii) lysis buffer 
(see section 2); (iv) detergent used for lysis (see section 2); and 
(v) time period of lysis (between 5 and 30 min) (data not 
shown). 
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3.2. The relative amounts of  the two cadherin-catenin complexes 
vary depending on the cell type 
Human Int 407, porcine LLC-PK1, and murine CSG and 
PCC4azal cells were metabolically labeled with [aSS]methion- 
ine, and cell lysates were immunoprecipitated with anti-or-, anti- 
fl-catenin or anti-plakoglobin a tibodies to investigate whether 
the results obtained with A431, human epidermoid carcino- 
ma cells, could be extended to other cell types (Fig. 3). Two 
E-cadherin--catenin complexes were also clearly detected in 
PCC4azal embryonal carcinoma cells when anti-fl-catenin or 
anti-plakoglobin antibodies were used for immunoprecipita- 
tions (Fig. 3, PCC4; fl-catenin migrates as a doublet in these 
cells, [24]). Similar results were obtained with the other cell 
lines; in LLC-PKI cells (or eEnd2 cells, not shown), more than 
one cadherin is expressed (Fig. 3, LLC-PK1). Also an addi- 
tional cadherin, with an electrophoretic mobility distinct from 
E-cadherin, is complexed either with cx- and fl-catenin or with 
~-catenin and plakoglobin. The identity of the cadherins of Int 
407 and LLC-PK1 cells were not further determined, but the 
protein bands were immunoreactive with an anti-pan-cadherin 
antibody in immunoblots (not shown) and therefore marked 
with 'Cad' for not determined cadherin. 
The relative abundance of the two complexes seems to vary 
depending on the cell type. While in A431 cells (see Figs. 1 and 
2) the two complexes appeared in roughly similar amounts, 
only a small amount of the complex was immunoprecipitated 
with anti-fl-catenin antibodies in Int 407 cells (Fig. 3, Int 407) 
or with anti-plakoglobin a tibodies in CSG and LLC-PKI cells 
(Fig. 3, CSG, LLC-PK1). The plakoglobin-containing complex 
was even less prevalent in CMT murine rectal carcinoma cells 
and existed only in trace amounts in LI-I  cells (data not 
shown). In all these experiments a constant amount of cell 
lysate was immunoprecipitated with an excess of affinity-puri- 
fied antibodies; thus these results clearly indicate a different 
relative distribution of the two complexes indifferent cell types. 
3.3. Analysis of cadherin-catenin complexes derived from the 
Triton X-lOO-insoluble fraction 
Cadherin-catenin complexes partition variably into the de- 
tergent-soluble and -insoluble cytolskeletal fractions, depend- 
ing on the cell type [25]. Therefore, we compared the complexes 
immunoprecipitated from the detergent-soluble and -insoluble 
fraction by anti-fl-catenin and anti-plakoglobin a tibodies (Fig. 
4). To make the Triton X-100-insoluble fraction accessible to 
immunoprecipitation, we sonified this material in the presence 
of lysis buffer containing 10% (w/v) betaine to release cadherin- 
catenin complexes without disrupting them. Hereby we avoided 
steps, like cross-linking of proteins prior to cell lysis, which 
might possibly alter the affiliation of the complexes to defined 
fractions. The fl-catenin and plakoglobin containing complexes 
immunoprecipitated in the detergent-soluble and -insoluble 
fractions with the respective antibodies are shown in Fig. 4 
(lanes 1-4). On long-time exposed fluorographs, residual 
fl-catenin or plakoglobin was detected in the reciprocal com- 
plexes, so the separation of fl-catenin and plakoglobin in two 
distinct complexes was apparently not complete. This phenom- 
enon was more pronounced in immunoprecipitations from the 
detergent-insoluble fraction (Fig. 4, lanes 1-4). These findings 
most likely reflect co-immunoprecipitation of a minor subpop- 
ulation of 'higher order complexes' including both cadherin- 
catenin complexes. 
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Fig. 3. Two complexes distinguished by antibodies against fl-catenin and plakoglobin were detected indifferent cell lines. Cell lysates of metabolically 
labeled CSG, Int 407, PCC4azal and LLC-PK1 cells were immunoprecipitated with antibodies as indicated. The relative amounts of the two 
complexes vary depending on cell lines (compare PCC4, CSG and Int 407). In LLC-PK1 cells another cadherin was detected. Cad, 'not further 
determined' cadherin; E, E-cadherin; ct,/~,pl, ~- and fl-catenin, and plakoglobin; Co, controls omitting antibodies. The Cad protein bands were 
immunoreactive with an anti-pan-cadherin antibody in immunoblots (not shown). 
Complexes immunoprecipitated by anti-plakoglobin anti- 
bodies contained additional proteins, including the cadherin 
desmoglein I. When the anti-plakogiobin immunoprecipitates 
shown in Fig. 4, lanes 2 and 4, were blotted and stained with 
anti-desmoglein I antibodies, desmoglein I was particularly en- 
riched in the immunoprecipitates from the Triton X100-insolu- 
ble, cytoskeletal fraction (Fig. 4, lanes 5 and 6). Association of 
desmoglein I with plakoglobin was also seen in immunoprecip- 
itates from cell lysates of MDBK cells with anti-desmoglein I 
antibodies (Fig. 4, lane 7), confirming earlier observations 
[14,26]. These data indicate that the anti-plakoglobin im- 
munoprecipitates derived from the detergent-soluble or -insolu- 
ble fraction are composed of two distinct cadherin--catenin 
complexes, with plakoglobin associated either with E-cadherin 
or with desmoglein I. Other co-immunoprecipitated proteins 
have not yet been identified. A promising candidate for the 
protein band at 45 kDa in the immunoprecipitates of the deter- 
gent-insoluble fraction (Fig. 4, lanes 3 and 4), is actin, but this 
band also appeared in control experiments without antibodies 
(not shown). 
4. Discussion 
Catenins were originally identified complexed to E-cadherin 
in immunopreclpitations with anti-E-cadherin antibodies [1,2]. 
More recently the primary structures of ct- and fl-catenin have 
been determined [5,6,16,27]. We confirm here that plakoglobin 
is most likely identical to y-catenin. In our earlier work the 
position of y-catenin in the complex was less clear, since the 
relative amount in the complex varied from cell type to cell type 
and since y-catenin was not consistently detected in all experi- 
ments [28]. Mainly for these reasons y-catenin was placed at the 
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Fig. 4. Partitioning of the two cadherin-catenin complexes in the Triton X-100-soluble and -insoluble fractions. The detergent-insoluble fraction of 
metabolically labeled A431 ceils was partially solubilized by sonicating the pellet in lysis buffer containing 10% (w/v) betaine, and subsequent 
immunoprecipitations were compared with those obtained from the detergent-soluble fractions (lanes 14). Complexes detected with anti-fl-catenin 
or anti-plakoglobin a tibodies separated into the detergent-soluble (S)and -insoluble (I) fractions. Anti-plakoglobin immunoprecipitates included 
additional proteins, suggesting a variety of protein associations, one of which is an association of plakoglobin with desmoglein I, as indicated by 
immunoblots of the immunoprecipitates shown in lanes 2 and 4 with anti-desmoglein I antibodies (lanes 5 and 6). An association ofplakoglobin 
with desmoglein I was also found in immunoprecipitates from cell lysates of metabolically labeled MDBK cells with monoclonal ntibodies to 
anti-desmoglein I (lane 7). S,I, Triton X-100-soluble and -insoluble fractions; dgI, desmoglein I; E, E-cadherin; 0~,fl,pl, ~-, fl-catenin, and plakoglobin. 
periphery of the cadherin-catenin complex. With the use of 
specific anti-plakoglobin a tibodies we add important new in- 
formation to our knowledge about the cadherin-catenin com- 
plex. Our results indicate that plakoglobin (y-catenin) binds, as 
does fl-catenin, directly to the cytoplasmic domain of E-cad- 
herin. Because of the high degree of homology between 
fl-catenin and plakoglobin in the central part of the proteins, 
this interaction might be mediated by a motif common to both 
proteins. 
We report here that two different E-cadherin-catenin com- 
plexes co-exist in the same cell, one composed of E-cadherin, 
~- and fl-catenin, and the other of E-cadherin, ~-catenin and 
plakoglobin. This finding is in full agreement with results re- 
cently published by W.J. Nelson's group [17,18]. More impor- 
tantly, we provide additional evidence for the co-existence of 
two distinct cadherin-catenin complexes in the same cell. Se- 
quential immunoprecipitations demonstrated that the two com- 
plexes are not obtained artifactually by affecting the molecular 
composition of a supposed single cadherin--catenin complex 
due to interference by the bound anti-fl-catenin or anti-plakog- 
lobin antibodies. We have used different cell lysis conditions, 
e.g. several detergents known to exhibit different solubilization 
properties, but have always obtained two distinct and separate 
complexes. This, and our observations that the relative 
amounts of the two complexes vary from cell type to cell type, 
very likely indicate that the solubilization procedure does not 
account for the results obtained. We therefore favor the possi- 
bility that the two cadherin-catenin complexes reflect a differ- 
ential association in which either fl-catenin or plakoglobin is 
bound to the cytoplasmic domain of a given cadherin in a 
mutually exclusive fashion. The variation of the relative 
amounts of the two complexes in different cell types may well 
turn out to have an important biological function. It remains 
to be investigated whether cadherin-mediated c ll-cell adhesion 
is indeed achieved independently of the type of complex that 
predominates in a cell. Besides E-cadherin, other cadherins, 
most likely N- or P-cadherin [15], can be also found in the two 
complexes. In the immunoprecipitations with anti-plakoglobin 
antibodies additional independent complexes are apparently 
detected, representing interaction of plakoglobin with desmo- 
glein I and/or other as yet unknown proteins. Recently, other 
proteins have been found in association with catenins. The 
product of a tumor suppressor gene, adenomatous polyposis 
coli (APC), forms a complex with ct-catenin and fl-catenin 
[29,30]. The epidermal growth factor (EGF) receptor associates 
with the cadherin-catenin complex after EGF stimulation of 
cells, and this interaction appears to be mediated by fl-catenin 
[31]. Possible consequences of such a differential ssociation of 
catenins with cadherins or other proteins in the same cell might 
be that these proteins can participate differentially in the con- 
struction of sub-cellular compartments, be differentially con- 
nected to the cytoskeletal network, and/or be differentially in- 
volved in signal transduction pathways. 
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